Quarterly report [Sections 13 or 15(d)]

Segment Reporting (Tables)

v3.26.1
Segment Reporting (Tables)
 3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information

Segment Reporting for the Quarter Ended March 31, 2026

 

    Treatment     Services     Segments Total     Corporate (1)     Consolidated Total  
    Treatment     Services     Segments Total     Corporate (1)     Consolidated Total  
Revenue from external customers   $ 7,878     $ 3,248     $ 11,126     $ —     $ 11,126  
Cost of Goods Sold:                                        
Payroll and benefits expenses     4,764       2,128       6,892       —       6,892  
Material and supplies expenses     1,345       —       1,345       —       1,345  
Disposal expenses     1,455       —       1,455       —       1,455  
Transportation expenses     389       —       389       —       389  
Subcontract expenses     —       5       5       —       5  
Other cost of goods sold (2)     2,758       1,163       3,921       —       3,921  
Total cost of goods sold     10,711       3,296       14,007       —       14,007  
Gross loss     (2,833 )     (48 )     (2,881 )     —       (2,881 )
SG&A:                                        
Payroll and benefits     877       610       1,487       997       2,484  
Other SG&A (3)     562       207       769       1,046       1,815  
Total SG&A     1,439       817       2,256       2,043       4,299  
Research and development     230       1       231       72       303  
Loss from operations   $ (4,502 )   $ (866 )   $ (5,368 )   $ (2,115 )     (7,483 )
Interest income                                     180  
Interest expense                                     (59 )
Interest expense-financing fees                                     (21 )
Other income                                     8  
Loss from continuing operations before taxes                                     (7,375 )
Income tax expense                                     —  
Loss from continuing operations, net of taxes                                   $ (7,375 )

 

Segment Reporting for the Quarter Ended March 31, 2025

 

    Treatment     Services     Segments Total     Corporate (1)     Consolidated Total  
    Treatment     Services     Segments Total     Corporate (1)     Consolidated Total  
Revenue from external customers   $ 9,186     $ 4,733     $ 13,919     $ —     $ 13,919  
Cost of Goods Sold:                                        
Payroll and benefits expenses     4,437       2,013       6,450       —       6,450  
Material and supplies expenses     1,351       —       1,351       —       1,351  
Disposal expenses     220       —       220       —       220  
Transportation expenses     495       —       495       —       495  
Subcontract expenses     —       908       908       —       908  
Other cost of goods sold (2)     2,433       1,405       3,838       —       3,838  
Total cost of goods sold     8,936       4,326       13,262       —       13,262  
Gross profit     250       407       657       —       657  
SG&A:                                        
Payroll and benefits     873       538       1,411       931       2,342  
Other SG&A (3)     483       198       681       992       1,673  
Total SG&A     1,356       736       2,092       1,923       4,015  
Research and development     291       23       314       69       383  
Gain on disposal of property and equipment     —       (5 )     (5 )     —       (5 )
Loss from operations   $ (1,397 )   $ (347 )   $ (1,744 )   $ (1,992 )     (3,736 )
Interest income                                     335  
Interest expense                                     (112 )
Interest expense-financing fees                                     (20 )
Other income                                     33  
Loss from continuing operations before taxes                                     (3,500 )
Income tax expense                                     —  
Loss from continuing operations, net of taxes                                   $ (3,500 )

 

(1) Amounts reflect the activity for corporate headquarters not included in the segment reporting information.
   
(2) Other cost of goods sold for each reportable segment includes:
   
 

Treatment - lab, regulatory, maintenance, depreciation and amortization, travel, outside services and general expenses.

 

Services - material and supplies, disposal, transportation, lab, regulatory, maintenance, depreciation and amortization, travel, outside services and general expenses.
   
(3) Other SG&A for each reportable segment and Corporate includes:
   
 

Treatment-depreciation and amortization, travel, outside services, maintenance and general expenses.

 

Services- travel, outside services, maintenance and general expenses.

 

Corporate-maintenance, depreciation and amortization, travel, outside services/public company and general expenses.
Schedule of Depreciation and Amortization

The following table presents depreciation and amortization for the three months ended March 31, (in thousands):

    2026     2025  
Treatment   $ 455     $ 381  
Services     24       44  
Total segment     479       425  
Corporate     11       11  
Total   $ 490     $ 436  
Schedule of Capital Expenditures

    2026     2025  
Treatment   $ 841     $ 487  
Services     18       36  
Total segment     859       523  
Corporate     —       —  
Total   $ 859     $ 523